Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-24

Clinical Trial Update: Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice

View source ↗

Summary

An observational study update of rituximab (Rituxan) in rheumatoid arthritis patients treated in routine clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituxan (rituximab)

Snippet

Sponsor: PerCuro Clinical Research Ltd | Conditions: Rheumatoid Arthritis | Status: UNKNOWN